Cargando…
Immunotherapy in COVID-19: why, who, and when?
Autores principales: | Sinha, Pratik, Calfee, Carolyn S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128672/ https://www.ncbi.nlm.nih.gov/pubmed/34015326 http://dx.doi.org/10.1016/S2213-2600(21)00232-0 |
Ejemplares similares
-
Who, what, and when—effective therapy for severe COVID-19
por: Kelmenson, Daniel A, et al.
Publicado: (2022) -
Offline: Why President Trump is wrong about WHO
por: Horton, Richard
Publicado: (2020) -
Why WHO needs a feminist economic agenda
por: Herten-Crabb, Asha, et al.
Publicado: (2020) -
COVID-19: why not learn from the past?
por: Zocchi, Elena, et al.
Publicado: (2021) -
RETRACTED: Chloroquine or hydroxychloroquine for
COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020)